Omega Therapeutics, specializing in gene therapy, conducted an IPO at an average price
Biotechnology company Omega Therapeutics, developing gene therapy for cancer and other diseases in the preclinical stage of research, attracted 126 million dollars, releasing 7,4 million shares in 17 dollars - within the stated range from 16 to 18 Dollars.